InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Crystal Adam, Directeur Médical. Insider active across 1 companies, notably C4 Therapeutics, Inc.. In total, 14 reports have been published. The latest transaction was disclosed on 26 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations14 total
€7,1971,102 shares@ €6.53130.0039% mcap0.9% of flow
Common Stock
SEC:0001209191-22-036712:0·
3,750 shares
Common Stock
SEC:0001209191-22-032514:0·
€86,13315,000 shares@ €5.74220.047% mcap22.6% of flow
Common Stock
SEC:0001209191-22-001700·
€86,13315,000 shares@ €5.74220.047% mcap11.2% of flow
Common Stock
SEC:0001209191-22-001700:0·
€28,7485,000 shares@ €5.74970.016% mcap7.6% of flow
Common Stock
SEC:0001209191-21-071069·
€28,7485,000 shares@ €5.74970.016% mcap3.7% of flow
Common Stock
SEC:0001209191-21-071069:0·
€56,14310,000 shares@ €5.61430.030% mcap14.7% of flow
Common Stock
SEC:0001209191-21-060230·
€56,14310,000 shares@ €5.61430.030% mcap7.3% of flow
Common Stock
SEC:0001209191-21-060230:0·
€64,53915,000 shares@ €4.30260.035% mcap17.0% of flow
Common Stock
SEC:0001209191-21-059512·
€64,53915,000 shares@ €4.30260.035% mcap8.4% of flow
Common Stock
SEC:0001209191-21-059512:0·
€62,81015,000 shares@ €4.18730.034% mcap16.5% of flow
Common Stock
SEC:0001209191-21-049114·
€62,81015,000 shares@ €4.18730.034% mcap8.2% of flow
Common Stock
SEC:0001209191-21-049114:0·
€82,30515,000 shares@ €5.4870.044% mcap21.6% of flow
Common Stock
SEC:0001209191-21-045691·
€82,30515,000 shares@ €5.4870.044% mcap10.7% of flow
Common Stock
SEC:0001209191-21-045691:0·
14 of 14 declarations
About Crystal Adam
Adam Crystal is the Chief Medical Officer at C4 Therapeutics, Inc. He oversees clinical activities and drug development strategies. His expertise in medicine and research is essential for guiding innovation and product safety.
